SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following favorable FDA feedback for its lead drug, sonelokimab, enabling a Biologics License Application submission for multiple indications without additional trials. This news is driving widespread community speculation about an accelerated path to market and significant analyst upgrades. Investors are actively discussing the drug's "best-in-class" potential for inflammatory skin diseases, fueling conversations around short squeeze opportunities and potential buyout offers from major pharmaceutical companies.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing increased scrutiny following a price target trim by Goldman Sachs and ongoing market skepticism surrounding its potential acquisition of Warner Bros. Discovery. Community sentiment is sharply divided, with many expressing frustration over recent price declines and concerns about the WBD deal, while others view the current valuation as a compelling buying opportunity ahead of anticipated strong earnings results. Investors are closely watching for signs of strength and clarity, particularly with Q4 earnings approaching, which could prove pivotal for the stock's direction amidst persistent acquisition drama.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited is trending due to recent news of a private placement and a significant acquisition, alongside the expiration of its IPO lock-up period. This low-float Hong Kong stock has ignited a fierce debate within the community, with many anticipating a short squeeze reminiscent of other volatile "China plays," while others warn of a rapid pump-and-dump scenario.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is a major talking point following news of Amazon Pharmacy offering Novo Nordisk's oral GLP-1 weight-loss pill, intensifying competitive concerns for HIMS which does not offer the product. This development, alongside a recent analyst downgrade, is fueling a deeply divided community, with many anticipating further declines while bullish investors view the significant pullback as an overblown reaction and a strategic long-term buying opportunity in the evolving telehealth market.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals is experiencing extreme volatility, fueled by a substantial special cash dividend and intense speculation around a potential pivot to blockchain assets. Community discussion is sharply divided between those anticipating a major short squeeze and turnaround driven by investor David Lazar's involvement, and others warning of a potential pump and dump given underlying fundamental concerns.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is a focal point of investor discussion as the biotech community anticipates potential updates at the upcoming JP Morgan Healthcare Conference, with many expressing frustration over the stock's underperformance despite robust Briumvi sales and an active M&A environment. Conversations are heavily focused on Briumvi's strong market share growth and best-in-class profile, the significant potential of a future subcutaneous formulation, and persistent buyout speculation, especially as competing BTK inhibitors face recent setbacks.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending due to recent government initiatives aimed at significantly lowering mortgage rates, including a substantial purchase of mortgage bonds, which has driven rates to their lowest in years and ignited optimism across the real estate sector. The community is actively discussing the potential for a continued rally and a gamma squeeze, with many anticipating further upside and cheering against short sellers as housing market activity is expected to surge.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending as widespread frustration mounts over warmer-than-expected winter weather forecasts, severely impacting natural gas demand. The community is vocal about significant losses, widely labeling the leveraged ETF a "widow maker" due to its inherent decay, while others debate a potential reversal, citing oversold conditions and the possibility of a polar vortex.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending following a significant $1 billion stock and warrant offering to an institutional investor, priced at a notable premium with warrants at a higher strike, signaling strong institutional confidence in the drone and defense technology company's future. The community is actively debating the short-term impact of dilution against the long-term growth potential, eagerly anticipating clarity on strategic acquisitions and contracts at its upcoming Investor Day.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

Rocket Companies is trending due to President Trump's proposed $200 billion mortgage bond purchase, which is widely expected to drive mortgage rates lower and stimulate the housing market. The community is buzzing with optimism for a significant refinance and home-buying boom, anticipating a strong upward re-rating for RKT. Traders are actively discussing the potential for new highs and a substantial surge, seeing current market conditions as a perfect storm for the company's integrated platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

FFFD
North Central Bancshares Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest FFFD News

FFFDNorth Central Bancshares Inc.